Pharmaceutical Executive-08-16-2005

Pharmaceutical Executive

This vaccine specialist is attempting to create a product that will protect people from influenza A for every future flu season without re-formulation. They are thinking about how to fight influenza B, too.

Pharmaceutical Executive

Migraine specialist abandons one problematic drug and maintains its position by filing an NDA the following week.

Pharmaceutical Executive

Only a year after the National Human Genome Research Institute called for improving sequencing technology, two new methods were announced in the same week. What will the goal of a $1000 human genome mean for medicine and disease research?